.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

ZAVESCA Drug Profile

« Back to Dashboard
Zavesca is a drug marketed by Actelion Pharms Ltd and is included in one NDA. It is available from one supplier.

The generic ingredient in ZAVESCA is miglustat. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the miglustat profile page.

Summary for Tradename: ZAVESCA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1

Pharmacology for Tradename: ZAVESCA

Clinical Trials for: ZAVESCA

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actelion Pharms Ltd
ZAVESCA
miglustat
CAPSULE;ORAL021348-001Jul 31, 2003RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZAVESCA

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actelion Pharms Ltd
ZAVESCA
miglustat
CAPSULE;ORAL021348-001Jul 31, 20035,472,969<disabled>
Actelion Pharms Ltd
ZAVESCA
miglustat
CAPSULE;ORAL021348-001Jul 31, 20035,525,616<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc